News

Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.

Why Do I Pheel This Way? Episode 2

Community

Why Do I Pheel This Way? Episode 2 Explores Social Life, Support and Self-Advocacy for Teens with Phenylketonuria

June 11, 2026

DNA of BioMarin Kim Warner

Kim Warner Builds Pathways for Early-Career Professionals Seeking Mission-Driven Opportunities

May 29, 2026

Carissah and Angela

Community

Crossing Paths: How the National MPS Society Reaches Families Where They Are

May 13, 2026

Stories

All Stories

Why Do I Pheel This Way? Episode 2

Community

Why Do I Pheel This Way? Episode 2 Explores Social Life, Support and Self-Advocacy for Teens with Phenylketonuria

June 11, 2026

DNA of BioMarin Kim Warner

Kim Warner Builds Pathways for Early-Career Professionals Seeking Mission-Driven Opportunities

May 29, 2026

Why Do I Pheel This Way?

Community

Why Do I Pheel This Way? New Video Podcast Series Sheds Light on Navigating Adolescence with Phenylketonuria

May 28, 2026

Carissah and Angela

Community

Crossing Paths: How the National MPS Society Reaches Families Where They Are

May 13, 2026

Savannah and her mom, DeAnna

Community

Finding a Way Forward: How the National MPS Society’s Pathways Program Supports Families at Diagnosis

May 6, 2026

Monica Mann presenting on stage

Monica Mann Reflects on a Life Dedicated to Healthcare Transformation

April 30, 2026

Press Releases

All Press Releases

BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026

June 16, 2026

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

May 20, 2026

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency

May 18, 2026

BioMarin Reports First Quarter 2026 Financial and Operating Results

May 4, 2026

BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society’s 2026 Annual Meeting

May 2, 2026

Company Statements

All Company Statements